Radiomics

Radiomics is a pioneering AI-driven clinical research organization (CRO) based in Leuven, Belgium, that transforms medical images into actionable data for oncology drug development. Its core offering combines a proprietary platform, Ikonics®, with advanced radiomics services to characterize disease, evaluate treatment response, and predict patient outcomes for clinical trial sponsors. The company partners with pharmaceutical firms like AstraZeneca and positions itself at the intersection of AI, medical imaging, and clinical research to enable data-driven decision-making in oncology trials.

Ikonics® - A fully integrated AI-powered image management and analysis platform for streamlining medical image collection, quality assessment, and radiomics feature extraction to support clinical research.

Radiomics competes in a crowded space that includes large, full-service imaging CROs (e.g., ICON, Parexel), specialized imaging analysis firms, and a growing number of AI-native medical imaging startups. Its differentiation lies in its specific focus on oncology radiomics and its integrated Ikonics® platform, but it must continually prove superior analytical insight to capture market share from established players.